674
Participants
Start Date
August 1, 2007
Primary Completion Date
April 7, 2016
Study Completion Date
September 7, 2017
Sunitinib malate
sunitinib malate 50 mg PO on schedule 4/2: 4 weeks on, 2 weeks off for 1 year or until disease recurrence or occurrence of a secondary malignancy, significant toxicity, or withdrawal of consent.
Placebo
Placebo PO for 1 year on schedule 4/2: 4 weeks on, 2 weeks off or until disease recurrence or occurrence of a secondary malignancy, significant toxicity, or withdrawal of consent
Instituto Nacional de Cancerologia - ESE, Bogota
Mater Misericordiae Hospital, Dublin
Beaumont Hospital, Dublin
AMNCH Hospital, Dublin
Taipei Veterans General Hospital, Taipei
Onkologisches Institut, Inselspital Bern, Bern
Monash Medical Centre - Moorabin Campus, East Bentleigh
Aarhus Universitetshospital, Aarhus C
Memorial Sloan Kettering Cancer Center, New York
Charite Universitaetsmedizin Berlin, Campus Charite Mitte, Berlin
National Cancer Center, Goyang-si
"Alexandra general hospital of Athens, department of Clinical Therapeutics, Oncology Unit", Athens
Charite Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin
Institut Paoli-Calmettes, Marseille
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si
Complexo Hospitalario Universitario A Coruna. Hospital Teresa Herrera, A Coruña
IRCCS AO Universitaria San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova
Fox Chase Cancer Center, Philadelphia
Fondazione IRCCS, Istituto Nazionale dei Tumori, SC Oncologia Medica 2, Milan
Universitaetsklinikum Hamburg-Eppendorf, Klinik fuer Urologie, Hamburg
Klinik und Poliklinik fuer Urologie, UKSH Campus Luebeck, Lübeck
Azienda Socio-Sanitaria Territoriale di Cremona, Ospedale di Cremona, Cremona
Duke University Medical Center, Durham
Hospital 12 de Octubre, Madrid
Carolina Urologic Research Center, Myrtle Beach
Emory University Hospital, Atlanta
The Emory Clinic, Inc, Atlanta
Medizinische Hochschule Hannover, Hanover
Institut Claudius Regaud - Centre de Lutte Contre le Cancer, Toulouse
Hopital Saint-Andre, Bordeaux
CRLC Val d'Aurelle, Montpellier
Centre Eugene Marquis, Rennes
CHRU de Tours - Hopital Bretonneau, Tours
Torre Medica Cristobal Colon, Acapulco de Juárez
Unita' Operativa di Oncologia Medica, Policlinico Sant'Orsola Malpighi, Bologna
Taichung Veterans General Hospital, Taichung
Institut de Cancerologie de l'Ouest - Centre Rene Gauducheau, Saint-Herblain
Instituto Valenciano de Oncologia, Valencia
Universitaetsklinikum Muenster Klinik und Poliklinik fuer Urologie, Münster
Institute of Oncology, Davidoff Center, Petah Tikva
RWTH Aachen, Urologische Klinik, Aachen
Universitaetsklinikum Bonn, Klinik und Poliklinik fuer Urologie, Bonn
Theageneio Anticancer Hospital, Thessaloniki
Centre Oscar Lambret, Lille
Klinikum der J. W. Goethe-Universitaet, Medizinische Klinik II, Frankfurt
Masarykuv onkologicky ustav, Brno
P.O.SS. ANNUNZIATA 14° LIVELLO CORPO A, Clinica Oncologica, Chieti Scalo
Universitaetsklinikum des Saarlandes, Klinik fuer Urologie und Kinderurologie, Homburg/Saar
Hopital Civil, Strasbourg
Hematology and Oncology Specialists, LLC, Metairie
Hematology and Oncology Specialists, LLC, Marrero
Assaf Harofeh Medical Center, Ẕerifin
Eberhardt-Karls-Universität Tübingen, Klinik für Urologie, Tübingen
Urologkliniken Akademiska Sjukhuset, Uppsala
Hopital Europeen Georges Pompidou, Paris
Divisione di Oncologia, AORN Antonio Cardarelli, Napoli
Ludwigs-Maximilians-Universitaet Muenchen, Klinikum Grosshadern Urologische Klinik und Poliklinik, München
Intermountain Medical Center, Murray
Universitaetsklinikum Ulm, Urologische Universitaetsklinik, Ulm
Ronald Reagan UCLA Medical Center Department of Pharmaceutical Services, Los Angeles
UCLA Clark Urology Center, Los Angeles
Klinikum Nuernberg, 5. Medizinische Klinik, Haematologie / Onkologie, Nuremberg
Sarawak General Hospital, Kuching
Institut Gustave Roussy / Service d'Immunotherapie, Villejuif
Cancer Institute & Hospital, CAMS, Beijing
Department of Urology,Peking University First Hospital, Beijing
Chinese PLA General Hospital/Urology Department, Beijing
Fudan University Cancer Hospital, Department of Urology, Shanghai
Huashan Hospital Fudan University, Shanghai
Urology Department, Renji Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai
Department of Urology, Shanghai Changhai Hospital, Shanghai
The first affiliated hospital of Soochow university/Department of Urology, Suzhou
Tianjin Oncology Hospital, urology department, Tianjin
The Second Hospital of Tianjin Medical University, Tianjin
Department of Urology, the Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou
Urology Department, South-Western Hospital, 3rd Military Medical University., Chongqing
Urology Department, Sun Yet-Sen University Cancer Center, Guangzhou
The University of North Carolina at Chapel Hill, Chapel Hill
Masarykuv onkologicky ustav, Brno
Fakultni nemocnice v Motole, Klinika zobrazovacich metod, Prague
Fakultni nemocnice v Motole, Radioterapeuticko-onkologicke oddeleni, Prague
Fakultni nemocnice v Motole, Ustav nuklearni mediciny, Prague
Krajska zdravotni a. s., Masarykova nemocnice v Usti nad Labem, o. z., Ústí nad Labem
Universitaetsklinikum Carl Gustav Carus der Technischen Universitaet Dresden, Dresden
Klinikum der Friedrich-Schiller-Universitaet Jena, Universitaetsklinik und Poliklinik fuer Urologie, Jena
University Hospital Galway, Galway
"Vesalius Sp. z o.o.", Krakow
Samodzielny Publiczny Zaklad Opieki Zdrowotnej, Uniwersytecki Szpital Kliniczny nr 2 im. Wojskowej A, Lodz
Uniwersytecki Szpital Kliniczny nr 2 im. Wojskowej Akademii Medycznej UM-Centralny Szpital Weteranow, Lodz
Oddzial Chemioterapii, Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego, Poznan
Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warsaw
Klinika Onkologii, Wojskowy Instytut Medyczny, Warsaw
Klinika Urologii i Onkologii Urologicznej Akademicki Szpital Kliniczny, Wroclaw
Univerzitna nemocnica Bratislava, Bratislava
Narodny Onkologicky ustav, Bratislava
Univerzitna nemocnica Martin, Martin
Fakultna nemocnica s poliklinikou, Žilina
Samsung Medical Center, Seoul
Asan Medical Center, Seoul
Korea University Anam Hospital, Seoul
Institut Catala D'Oncologia (I.C.O), L'Hospitalet de Llobregat
Hospital Universitario Vall D'Hebron, Barcelona
Hospital Clinico de Barcelona, Barcelona
Verksamheten urologi, SU/Sahlgrenska, Gothenburg
Onkologiska kliniken, Universitetssjukhuset, Lund
Norrlands universitetssjukhus, Urologiska kliniken, Umeå
Akademiska sjukhuset, Uppsala
Centrallasarettet, Onkologkliniken, Västerås
Kantonsspital St. Gallen, Sankt Gallen
The Beatson West of Scotland Cancer Centre, Glasgow
Ross Hall Hospital, Glasgow
Post Graduate Medical School, University of Surrey, Guildford
Guy's Hospital, London
St. Mary's Hospital, Imperial College, Health care NHS Trust, London
Medical Oncology, Patterson institute for Cancer Research, Manchester
Lead Sponsor
Pfizer
INDUSTRY